Table 1.
Baseline characteristics
| Total | |
|---|---|
| N (%) | 163 (100) |
| Age, mean (SD) | 48.2 (10.4) |
| Male sex, n (%) | 96 (58.9) |
| Dyslipidemia, n (%) | 109 (66.9) |
| Diabetes, n (%) | 34 (20.9) |
| Smoking, n (%) | 124 (76.1) |
| Hypertension, n (%) | 62 (38.0) |
| Obesity, n (%) | 63 (38.7) |
| LDL, unmeasurable, n (%) | 12 (7.4) |
| mean (SD) | 2.5 (0.9) |
| HDL, mean (SD) | 1.3 (0.4) |
| Triglyceride, mean (SD) | 2.3 (2.3) |
| CAC score | |
| 25th percentile | 0 |
| 50th percentile | 0 |
| 75th percentile | 6 |
| 90th percentile | 114 |
| Duration of schizophrenia | |
| n (%) | 141 (100) |
| mean years (SD) | 19.7 (8.2) |
| Severity of schizophreniaa | |
| n (%) | 155 (100) |
| Normal, not at all ill (1 point) | 1 (0.6) |
| Borderline mentally ill (2 points) | 23 (15) |
| Mildly ill (3 points) | 45 (29) |
| Moderately ill (4 points) | 49 (32) |
| Markedly ill (5 points) | 26 (17) |
| Severely ill (6 points) | 10 (6) |
| Among the most extremely ill (7 points) | 1 (0.6) |
| CGI-SCH scorea, mean (SD) | 3.7 (1.2) |
| Clozapine treatment, n (%) | 41 (25.2) |
aBased on the CGI-SCH rating scale for overall severity.